PSYCHOSIS IN PARKINSON'S DISEASE PATIENTS

被引:0
|
作者
Rahman, Abdul Hamid Abdul [1 ]
Abu Samah, Ibrahim [2 ]
Saini, Suriati Mohamed [1 ]
机构
[1] UKMMC, Dept Psychiat, Kuala Lumpur 56000, Malaysia
[2] Hosp Muar, Dept Psychiat & Mental Hlth, Muar, Malaysia
来源
ASEAN JOURNAL OF PSYCHIATRY | 2013年 / 14卷 / 02期
关键词
Psychosis; Parkinson; Associated Factors;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The objective of this study is to determine the prevalence and factors associated with psychosis in Parkinson's disease (PD) patients. Method: This is a cross-sectional study of 108 PD patients from neurological clinic UKM Medical Centre and Kuala Lumpur Hospital. The patients were recruited from August to December 2004. Psychosis was determined using SCID, the severity of psychosis was rated using BPRS. The cognitive functions were evaluated with MMSE and the severity of depression was assessed with HAM-D. Results: The result shows that the prevalence of psychosis in Parkinson's disease patients in this sample was 13%. The psychosis was found to be significantly associated with advancing age, duration of illness, severity of depression and cognitive impairment. Multivariate analysis demonstrates that severity of depression (OR = 1.08, 95% C.I. = 1.01 - 1.16) and advancing age (OR = 4.72, 95% C.I. = 1.37 - 16.29) increased risk of psychosis in PD patients. Conclusion: We found that advancing age and severity of depression increase risk to develop psychosis in patients with PD.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 50 条
  • [1] Managing psychosis in patients with Parkinson's disease
    Cummings, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10): : 801 - 803
  • [2] Risk factors for psychosis in patients with Parkinson's disease
    Rocha, M. S. G.
    Borges, R. G.
    Costa, C. D. M.
    Oliveira, M. O.
    Brucki, S. M. D.
    Godinho, F. F.
    Gordon, P. C.
    [J]. MOVEMENT DISORDERS, 2015, 30 : S61 - S62
  • [3] Pharmacological interventions for psychosis in Parkinson's disease patients
    Friedman, Joseph H.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (05) : 499 - 505
  • [4] Treatment of memory and psychosis in patients with Parkinson's disease
    Isaacson, SH
    Kreitzman, DL
    [J]. MOVEMENT DISORDERS, 2005, 20 : S145 - S145
  • [5] Levodopa psychosis in patients with idiopathic Parkinson's disease
    García-Escrig, M
    Pareja, FB
    Ponsatí, JTF
    [J]. MEDICINA CLINICA, 1999, 112 (07): : 245 - 250
  • [6] Delirium, Psychosis and Dementia in Patients with Parkinson's Disease
    Klingelhoefer, L.
    Reichmann, H.
    [J]. AKTUELLE NEUROLOGIE, 2011, 38 (06) : 303 - 308
  • [7] Longitudinal outcome of Parkinson's disease patients with psychosis
    Factor, SA
    Feustel, PJ
    Friedman, JH
    Comella, CL
    Goetz, CG
    Kurlan, R
    Parsa, M
    Pfeiffer, R
    [J]. NEUROLOGY, 2003, 60 (11) : 1756 - 1761
  • [8] Factors associated with psychosis in patients with Parkinson's disease
    Esparza, Claudia
    Garza, David
    Cervantes, Amin
    Salinas, Karla
    Isais, Sara
    Anaya, Antonio
    Velazquez, Edna
    Banegas, Alejandro
    Gonzalez, Arnulfo
    Rodriguez, Mayela
    Martinez, Daniel
    [J]. NEUROLOGY, 2020, 94 (15)
  • [9] Cognitive correlates of psychosis in patients with Parkinson's disease
    Moustafa, Ahmed A.
    Krishna, Rakhee
    Frank, Michael J.
    Eissa, Abeer M.
    Hewedi, Doaa H.
    [J]. COGNITIVE NEUROPSYCHIATRY, 2014, 19 (05) : 381 - 398
  • [10] Cognitive dysfunction in patients with Parkinson's disease and psychosis
    Lenka, A.
    Hegde, S.
    Arumugham, S.
    Yadav, R.
    Pal, P.
    [J]. MOVEMENT DISORDERS, 2019, 34